Back to Ovarian Cancer
NCT06970821
NCT06970821
Who may be able to join
Who might be able to join this trial:
- You are a female teenager between the ages of 13 and 19
- You got your first period at least 2 years before joining the study
- (For the PCOS group) You have been diagnosed with polycystic ovary syndrome (PCOS), meaning you have irregular periods and signs of higher-than-normal male hormones (either from symptoms or a blood test)
- (For the Control/comparison group) You have regular periods that come every 21 to 35 days, and you do NOT have signs of higher-than-normal male hormones
Who may not be able to join:
- You have taken any medications in the past 6 months that affect vitamin D, blood sugar sensitivity, or hormone levels — for example, birth control pills, insulin-related medications, or vitamin D supplements
- You have a hormonal or gland-related condition such as congenital adrenal hyperplasia, high prolactin levels, Cushing's syndrome, or a thyroid problem
- You have a long-term illness affecting your whole body, such as diabetes, or serious liver or kidney disease
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Bagcilar Training and Research Hospital
Registry
clinicaltrials_gov
Start date
1 March 2024
Est. completion
15 May 2025
Where this trial is recruiting
Turkey (Türkiye)
Primary endpoints
Serum 25(OH)D Level at Baseline; Body Mass Index (BMI) at Baseline; HOMA-IR Value at Baseline; Serum Lipid Profile at Baseline; Visceral Adipose Tissue Thickness, Subcutaneous Adipose Tissue Thickness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.